Salvador Alejo

8PUBLICATIONS
27CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsMolecular imaging (incl. electron microscopy and neutron diffraction)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 23, 2026
HELZ-BRCA2 complex resolves R-loops to drive transcription-coupled homologous recombination.

|Aug 16, 2024
DSS1 restrains BRCA2's engagement with dsDNA for homologous recombination, replication fork protection, and R-loop homeostasis.

Yuxin Huang, Wenjing Li, Tzeh Foo

|Jul 11, 2024
KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer.

Yihong Chen, Jessica D Johnson, Sridharan Jayamohan

|Apr 13, 2023
Reticulocalbin 3 Is a Novel Mediator of Glioblastoma Progression.

Yi He, Salvador Alejo, Jessica D Johnson

|Jan 18, 2023
Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma.

Salvador Alejo, Bridgitte E Palacios, Prabhakar Pitta Venkata

|Jul 09, 2022
Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist.

Yi He, Salvador Alejo, Prabhakar Pitta Venkata

Pageof 2

Frequent Collaborators

2 joint publications

Fei Lu

2 joint publications

Hui Zhang

2 joint publications

Gangadhara R Sareddy

2 joint publications

Wenjing Li